Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cedric Salone"'
Autor:
Samantha Walczuk, Francesca E. Cunningham, Xinhua Zhao, Diane Dong, Peter A. Glassman, Donald R. Miller, Deborah Khachikian, Anthony Au, Cedric Salone, Kelly Bryan, Qoua Her, Sherrie L. Aspinall
Publikováno v:
Pharmacoepidemiology, Vol 3, Iss 1, Pp 103-116 (2024)
We described insulin glargine (originator) and insulin glargine-yfgn (biosimilar) treatment patterns, assessed effectiveness and safety outcomes, and identified reasons for switching back to the originator product from the biosimilar. This retrospect
Externí odkaz:
https://doaj.org/article/a298ba3cf45d4a1b980727b718f42035
Autor:
Jing Luo, Kwan Hur, Cedric Salone, Nina Huang, Muriel Burk, Lucy Pandey, Bharat Thakkar, Mark Donahue, Francesca Cunningham
Publikováno v:
Open Forum Infectious Diseases.
Background Although the benefits outweigh risks, COVID-19 vaccines have been associated with an increased risk of myocarditis and pericarditis. This is a national US Veteran population-based report of confirmed myocarditis/pericarditis following mRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d6bdb9b5c46804b39719a9bef8facaa
https://doi.org/10.1093/ofid/ofad268
https://doi.org/10.1093/ofid/ofad268
Autor:
Sama A Alabbas, Rong Jiang, Anthony Au, Michelle Vu, Von R Moore, Francesca E Cunningham, Kevin Stroupe, Mark Bounthavong, Peter A Glassman, Chester B Good, Cedric Salone, Sherrie L Aspinall
Publikováno v:
American Journal of Health-System Pharmacy.
Purpose Costs of hospitalization due to severe adverse drug reactions (ADRs) were previously estimated within the Veterans Health Administration (VHA), but additional analyses are needed to infer potential interventions to mitigate these negative out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e43fbcbf655d661661f521989d4a01b
https://doi.org/10.1093/ajhp/zxad060
https://doi.org/10.1093/ajhp/zxad060
Autor:
Rupak Datta, Kathleen M Akgün, Alexis Barrett, Ann Fisher, Cedric Salone, Francesca E. Cunningham, Muriel Burk, Anthony Au, Louise M. Dembry
Publikováno v:
Infection Control and Hospital Epidemiology
We evaluated adverse drug events (ADEs) by chart review in a random national sample of 428 veterans with coronavirus disease 2019 (COVID-19) who received tocilizumab (n = 173 of 428). ADEs (median time, 5 days) occurred in 51 of 173 (29%) and include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eea58dc50432f058353e44ea4fd8499e
https://doi.org/10.1017/ice.2021.227
https://doi.org/10.1017/ice.2021.227